FSSAI has issued notices to Nestle India and Zydus Wellness over alleged misleading claims in Lactogen Pro 1, Nan Excella Pro Stage 1 and Complan, seeking scientific evidence to support the claims.
The food regulator flagged a "Flavoured Milk" vs "Proprietary Food" mismatch on Nescafe drinks, and bone-health and "no added sugar" claims on Horlicks
Food regulator FSSAI has issued notices to Nestle India and Hindustan Unilever Ltd for misleading claims on the packaging of some of their food products. In a social media post on Saturday, the Food Safety and Standards Authority of India said notices have been issued against these two companies "regarding misleading claims and non-compliances". In the case of HUL, the notice has been issued for misleading claims on its product 'Horlicks Women's Plus Chocolate Nutrition Drink 400g'. "Claims such as 'Nutrition for Strong Bones', 'Clinically Proven to Help Improve Bone Strength in 6 Months' and 'Improves Bone Health' were found to be misleading or non-compliant with applicable regulations," FSSAI said. The claim 'healthy Muscles' was found to be in contravention of the provisions governing the use of the term "healthy" in food claims. Apart from that, the claim "No Added Sugar" was considered misleading in view of the presence of maltodextrin in the product, the regulator pointed ..
Nestle posted 20% revenue growth and improved margins in Q2FY27, but concerns over slowing growth, input costs and premium valuations have prompted brokerages to cut target multiples
Analysts said that Nestle India's sales growth is expected to be optically lower in H2FY27 vs H1FY27, which is more due to the base effect and not led by any deterioration in the fundamentals.
Nestle India's revenue rose 20.3% to ₹6,788.3 crore in Q2FY27, driven by double-digit volume growth, while its shares fell 7.76% amid concerns over rising food inflation
Nestle India on Thursday reported a 36.3% YoY growth in Q2FY27 net profit at ₹1,026.70 crore, backed by a 20.5% YoY surge in sales to ₹6,782.17 crore.
FMCG major Nestle India on Thursday reported a 36.32 per cent rise in consolidated net profit at Rs 1,026.77 crore for the September quarter of FY27, on a year-on-year basis. The company had posted a consolidated net profit of Rs 743.17 crore in the corresponding period last fiscal, Nestle India said in a regulatory filing. Nestle India's revenue from sale of products rose 20.45 per cent to Rs 6,782.17 crore in July-September quarter of FY27. This was Rs 5,630.23 crore in the corresponding period a year ago. "The quarter saw a continuation of strong and broad-based growth across all product groups, with total sales reaching INR 6,782.2 crore, with a growth of 20.5 per cent, which was driven by robust, double-digit volume growth," said Chairman and Managing Director Manish Tiwary. The company continued to focus on operational efficiencies while significantly increasing investments behind its brands, with advertising and marketing spend up 46 per cent. "EBITDA margin remained health
Q2FY27 results today: Jio Financial, Wipro, Nestle India, HDFC AMC, HDFC Life, and Indian Bank, and 43 other firms will announce their earnings for the second quarter of financial year 2026-27
Consumption recovery has been gradually strengthening and, while the market has started pricing in an improvement, the outlook remains dependent on the durability of demand
Nestle India could outperform peers, supported by strong brand franchises, resilient demand, efficient distribution networks and disciplined cost management, said brokerages.
The regulator also suspended Shreyash Retail's licence over expired and rotten food products and sanctioned prosecution against Nex International over excessive pesticide residues
A sample of "low-fat dairy whitener" manufactured by Nestle India, drawn from the premises of Hotel Lalit in Connaught Place in the national capital, has been found "unsafe and substandard", the Food Safety and Standards Authority of India (FSSAI) said. In a post on social media, the food regulator said a sample was collected from the premises of Bharat Hotels Ltd (The Lalit), Connaught Place, New Delhi. According to the FSSAI, the report of the food analyst's laboratory declared the product "substandard" and "unsafe", indicating non-compliance under the Food Safety and Standards (FSS) Act, 2006. A copy of the laboratory analysis report was provided to the food business operator (FBO) for reference and necessary action, the regulator said. A notice has also been issued to Bharat Hotels Ltd over the non-compliant product. The FBO was given an opportunity to appeal against the food analyst's report under the relevant section of the FSS Act, 2006, within the prescribed period. The FB
The Food regulator filed three separate adjudication cases against Nestle India in connection with the non-compliances involving infant nutrition products.
The regulator's adjudication sanction lists promotional claims made for the products and a laboratory finding related to biotin content among the issues
The regulator alleges prohibited promotional claims in two infant nutrition products and says a follow-up formula sample failed to meet the prescribed biotin requirement
The Food Safety and Standards Authority of India (FSSAI) on Friday said it has initiated legal action against Nestle India Ltd for alleged non-compliance with food safety norms in three infant nutrition products. According to FSSAI, it examined NAN Excella Pro Stage 1, Lactogen Pro 1, and a follow-up formula along with their promotional material available on e-commerce platforms. In NAN Excella Pro Stage 1, the regulator flagged claims relating to "5HMOs" and "Whey Protein," while in Lactogen Pro 1, it observed a claim describing "Whey Protein" as easy to digest, the regulator said in a social media post. FSSAI said it had sought clarifications from Nestle India on these claims. Both the products were found to be in contravention of Regulation 4(2) of the Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2020, which restrict promotional claims or material aimed at increasing the saleability of infant foods, as well as Section 3 of the Infant Milk Substitutes, Feed
Nearly 80% of products made by India's more than $100 billion packaged food and beverages market could be regarded as high in fat, sugar and salt, according to industry estimates
Nestle CEO Philipp Navratil said India is the group's highest-performing market in H1 2026 and welcomed front-of-pack labelling, while signalling scope for more local manufacturing
India's emergence among the top five global markets for Nestle SA is now "on the horizon", the Swiss food and beverage giant's CEO Philipp Navratil said on Wednesday. The India market is "very attractive" for Nestle and the company expects a volume-led growth there with support of investments, said Navratil, who is on a visit to India. Nestle sees "plenty of growth opportunities" in India, which is among its top ten markets and already the highest-performing for the group in terms of growth, he added. "India, in terms of growth, is one of the highest performers of the group and was the highest-performing market in the first half of 2026. It is among the top 10 markets and there continues to be further opportunity here to drive. Top five (in terms of topline contribution) is definitely on the horizon," Navratil said in a select media roundtable. When asked about the timeframe for India entering the top five list, he said the ambition was very much within near-term rather than a dist